Alkermes plc (ALKS) | Financial Analysis & Statements
Alkermes plc Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
384.5M
Gross Profit
338.3M
87.98%
Operating Income
58.1M
15.11%
Net Income
49.3M
12.83%
Balance Sheet Metrics
Total Assets
2.5B
Total Liabilities
667.7M
Shareholders Equity
1.8B
Debt to Equity
0.37
Cash Flow Metrics
Operating Cash Flow
171.8M
Free Cash Flow
170.1M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Alkermes plc Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.5B | 1.6B | 1.7B | 1.1B | 1.2B |
| Cost of Goods Sold | 196.5M | 245.3M | 253.0M | 218.1M | 197.3M |
| Gross Profit | 1.3B | 1.3B | 1.4B | 893.7M | 976.4M |
| Gross Margin % | 86.7% | 84.2% | 84.8% | 80.4% | 83.2% |
| Operating Expenses | |||||
| Research & Development | 324.0M | 245.3M | 270.8M | 272.7M | 290.9M |
| Selling, General & Administrative | 701.5M | 645.2M | 689.8M | 590.8M | 549.6M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 1.0B | 890.6M | 960.6M | 863.5M | 840.5M |
| Operating Income | 254.0M | 420.6M | 414.1M | -6.1M | 97.7M |
| Operating Margin % | 17.2% | 27.0% | 24.9% | -0.5% | 8.3% |
| Non-Operating Items | |||||
| Interest Income | 45.3M | 42.4M | 30.9M | 7.6M | 2.4M |
| Interest Expense | 12.3M | 22.6M | 23.0M | 13.0M | 11.2M |
| Other Non-Operating Income | 4.5M | 3.2M | -425.0K | -19.6M | -1.2M |
| Pre-tax Income | 291.4M | 443.8M | 421.5M | -31.1M | 87.7M |
| Income Tax | 49.8M | 71.6M | -97.6M | 2.0M | 11.3M |
| Effective Tax Rate % | 17.1% | 16.1% | -23.2% | 0.0% | 12.9% |
| Net Income | 241.7M | 367.1M | 355.8M | -158.3M | -48.2M |
| Net Margin % | 16.4% | 23.6% | 21.4% | -14.2% | -4.1% |
| Key Metrics | |||||
| EBITDA | 330.9M | 494.9M | 519.5M | 81.5M | 179.0M |
| EPS (Basic) | $1.47 | $2.22 | $2.14 | $-0.97 | $-0.30 |
| EPS (Diluted) | $1.43 | $2.17 | $2.10 | $-0.97 | $-0.30 |
| Basic Shares Outstanding | 164703000 | 165392000 | 166223000 | 163742000 | 160942000 |
| Diluted Shares Outstanding | 164703000 | 165392000 | 166223000 | 163742000 | 160942000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Alkermes plc Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 388.6M | 291.1M | 457.5M | 292.5M | 337.5M |
| Short-term Investments | 199.6M | 460.5M | 316.0M | 316.0M | 198.8M |
| Accounts Receivable | 268.6M | 315.3M | 229.6M | 216.2M | 313.2M |
| Inventory | 196.6M | 182.9M | 186.4M | 181.4M | 150.3M |
| Other Current Assets | 79.1M | 91.3M | 98.2M | 41.2M | 49.0M |
| Total Current Assets | 1.9B | 1.4B | 1.5B | 1.1B | 1.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 77.2M | 84.2M | 91.5M | 97.5M | 115.6M |
| Goodwill | 166.9M | 166.9M | 168.0M | 203.7M | 259.8M |
| Intangible Assets | 815.0K | 890.0K | 2.0M | 37.7M | 74.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 174.9M | 171.3M | 207.4M | 260.9M | 109.3M |
| Total Non-Current Assets | 557.8M | 640.2M | 650.7M | 833.7M | 962.3M |
| Total Assets | 2.5B | 2.1B | 2.1B | 2.0B | 2.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 108.0M | 45.6M | 65.6M | 32.8M | 55.7M |
| Short-term Debt | 6.7M | 6.2M | 8.7M | 12.9M | 19.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | 4.5M | 5.8M | - |
| Total Current Liabilities | 543.4M | 465.2M | 520.2M | 497.7M | 471.3M |
| Non-Current Liabilities | |||||
| Long-term Debt | 63.3M | 69.4M | 363.4M | 366.6M | 397.0M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 61.0M | 56.0M | 49.9M | 42.4M | 43.6M |
| Total Non-Current Liabilities | 124.3M | 125.4M | 413.3M | 422.5M | 440.6M |
| Total Liabilities | 667.7M | 590.6M | 933.5M | 920.2M | 911.9M |
| Equity | |||||
| Common Stock | 1.8M | 1.8M | 1.7M | 1.7M | 1.7M |
| Retained Earnings | -734.8M | -976.5M | -1.3B | -1.7B | -1.5B |
| Treasury Stock | 450.3M | 419.3M | 189.3M | 160.9M | 142.7M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.8B | 1.5B | 1.2B | 1.0B | 1.1B |
| Key Metrics | |||||
| Total Debt | 70.0M | 75.5M | 372.2M | 379.4M | 416.2M |
| Working Capital | 1.4B | 950.2M | 965.3M | 632.6M | 590.9M |
Balance Sheet Composition
Alkermes plc Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 241.7M | 367.1M | 355.8M | -158.3M | -48.2M |
| Depreciation & Amortization | 27.2M | 28.5M | 74.9M | 77.9M | 78.7M |
| Stock-Based Compensation | 98.7M | 96.6M | 100.9M | 94.3M | 87.6M |
| Working Capital Changes | 143.6M | -109.2M | -13.3M | 3.1M | -48.5M |
| Operating Cash Flow | 545.2M | 428.1M | 424.7M | 11.5M | 78.7M |
| Investing Activities | |||||
| Capital Expenditures | -39.3M | -33.0M | -47.7M | -38.3M | -27.7M |
| Acquisitions | 1.7M | 98.0M | 0 | 1.8M | 7.9M |
| Investment Purchases | -364.4M | -486.5M | -254.5M | -309.7M | -340.4M |
| Investment Sales | 697.5M | 310.3M | 355.5M | 281.6M | 295.0M |
| Investing Cash Flow | 295.5M | -111.3M | 53.4M | -63.3M | -57.3M |
| Financing Activities | |||||
| Share Repurchases | 0 | -200.3M | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | 0 | 0 | 23.6M |
| Debt Repayment | 0 | -291.8M | -3.0M | -3.0M | -3.2M |
| Financing Cash Flow | -31.0M | -521.7M | -306.5M | -21.2M | 3.8M |
| Free Cash Flow | 480.3M | 405.6M | 353.3M | -17.2M | 72.7M |
| Net Change in Cash | 809.7M | -205.0M | 171.6M | -73.0M | 25.2M |
Cash Flow Trend
Alkermes plc Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.71
Forward P/E
48.44
Price to Book
3.09
Price to Sales
3.83
PEG Ratio
-0.36
Profitability Ratios
Profit Margin
16.37%
Operating Margin
15.11%
Return on Equity
14.72%
Return on Assets
6.99%
Financial Health
Current Ratio
3.55
Debt to Equity
3.85
Beta
0.39
Per Share Data
EPS (TTM)
$1.43
Book Value per Share
$10.99
Revenue per Share
$8.96
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ALKS | 5.6B | 23.71 | 3.09 | 14.72% | 16.37% | 3.85 |
| Zoetis | 49.8B | 19.58 | 15.04 | 65.99% | 28.24% | 279.59 |
| Haleon Plc - ADR | 42.4B | 18.72 | 1.88 | 10.27% | 15.11% | 52.37 |
| Lantheus Holdings | 5.4B | 24.30 | 4.91 | 21.45% | 15.15% | 57.19 |
| Amneal | 4.2B | 63.23 | -57.42 | -101.02% | 2.39% | 45,095.52 |
| Indivior PLC | 4.0B | 20.22 | -42.07 | -212.12% | 16.95% | -3.55 |
Financial data is updated regularly. All figures are in the company's reporting currency.






